Combination of Estrogen Receptor Alpha and Histological Type Helps to Predict Lymph Node Metastasis in Patients with Stage IA2 to IIA2 Cervical Cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Koh WJ, Abu-Rustum NR, Bean S, et al. Cervical cancer, Version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(1):64–84. doi:10.6004/jnccn.2019.0001
   PubMed Web of Science ®Google Scholar
• Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018;143(Suppl 2):S22–S36. doi:10.1002/ijgo.12611
   PubMed Web of Science ®Google Scholar
• Soisson AP, Soper JT, Clarke-Pearson DL, Berchuck A, Montana G, Creasman WT. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol. 1990;37:390–395. doi:10.1016/0090-8258(90)90374-T
   PubMed Web of Science ®Google Scholar
• Fiorica JV, Roberts WS, Greenberg H, Hoffman MS, LaPolla JP, Cavanagh D. Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy. Gynecol Oncol. 1990;36(3):343–347. doi:10.1016/0090-8258(90)90139-C
   PubMed Web of Science ®Google Scholar
• Rizzo S, Calareso G, Maccagnoni S, et al. Pre-operative MR evaluation of features that indicate the need of adjuvant therapies in early stage cervical cancer patients. A single-centre experience. Eur J Radiol. 2014;83:858–864.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang J, Yang J, et al. The role of magnetic resonance imaging in pretreatment evaluation of early-stage cervical cancer. Int J Gynecol Cancer. 2014;24:1292–1298. doi:10.1097/IGC.0000000000000169
   PubMed Web of Science ®Google Scholar
• Bipat S, Glas AS, van der Velden J, Zwinderman AH, Bossuyt PM, Stoker J. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol. 2003;91:59–66. doi:10.1016/S0090-8258(03)00409-8
   PubMed Web of Science ®Google Scholar
• Liu J, Li Y, Chen X, et al. Upregulation of miR-205 induces CHN1 expression, which is associated with the aggressive behaviour of cervical cancer cells and correlated with lymph node metastasis. BMC Cancer. 2020;20(1):1029. doi:10.1186/s12885-020-07478-w
   PubMed Web of Science ®Google Scholar
• Zhai Y, Bommer GT, Feng Y, Wiese AB, Fearon ER, Cho KR. Loss of estrogen receptor 1 enhances cervical cancer invasion. Am J Pathol. 2010;177(2):884–895. doi:10.2353/ajpath.2010.091166
   PubMed Web of Science ®Google Scholar
• Park Y, Baik S, Ho C, Lin CY, Chung SH. Progesterone receptor is a haploinsufficient tumor suppressor gene in cervical cancer. Mol Cancer Res. 2021;19(1):42–47. doi:10.1158/1541-7786.MCR-20-0704
   PubMed Web of Science ®Google Scholar
• Chung SH, Shin MK, Korach KS, Lambert PF. Requirement for stromal estrogen receptor alpha in cervical neoplasia. Horm Cancer. 2013;4(1):50–59. doi:10.1007/s12672-012-0125-7
   PubMed Web of Science ®Google Scholar
• Chen HH, Chen SP, Zheng QL, et al. Genistein promotes proliferation of human cervical cancer cells through estrogen receptor-mediated PI3K/Akt-NF-κB pathway. J Cancer. 2018;9:288–295. doi:10.7150/jca.20499
   PubMed Web of Science ®Google Scholar
• Zhang E, Zhang Y, Fan Z, Cheng L, Han S, Che H. Apigenin inhibits histamine-induced cervical cancer tumor growth by regulating estrogen receptor expression. Molecules. 2020;25(8):1960.
   PubMed Web of Science ®Google Scholar
• Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet. 2009;105(2):107–108. doi:10.1016/j.ijgo.2009.02.009
   PubMed Web of Science ®Google Scholar
• Hong MK, Wang JH, Su CC, Li MH, Hsu YH, Chu TY. Expression of estrogen and progesterone receptor in tumor stroma predicts favorable prognosis of cervical squamous cell carcinoma. Int J Gynecol Cancer. 2017;27(6):1247–1255. doi:10.1097/IGC.0000000000001004
   PubMed Web of Science ®Google Scholar
• Kwasniewska A, Postawski K, Gozdzicka-Jozefiak A, et al. Estrogen and progesterone receptor expression in HPV-positive and HPV-negative cervical carcinomas. Oncol Rep. 2011;26:153–160. doi:10.3892/or.2011.1256
   PubMed Web of Science ®Google Scholar
• den Boon JA, Pyeon D, Wang SS, et al. Molecular transitions from papillomavirus infection to cervical precancer and cancer: role of stromal estrogen receptor signaling. Proc Natl Acad Sci U S A. 2015;112(25):E3255–64. doi:10.1073/pnas.1509322112
   PubMed Web of Science ®Google Scholar
• Fan DM, Tian XY, Wang RF, Yu JJ. The prognosis significance of TGF-β1 and ER protein in cervical adenocarcinoma patients with stage Ib~IIa. Tumour Biol. 2014;35(11):11237–11242. doi:10.1007/s13277-014-2110-y
   PubMedGoogle Scholar
• Zhang X, Zhang A, Zhang X, et al. ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells. Virus Res. 2021;306:198602. doi:10.1016/j.virusres.2021.198602
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wu YZ, Zhang YM, Ji XH, Hao Q. Activation of G-protein coupled estrogen receptor inhibits the proliferation of cervical cancer cells via sustained activation of ERK1/2. Cell Biochem Funct. 2015;33(3):134–142. doi:10.1002/cbf.3097
   PubMed Web of Science ®Google Scholar
• Son J, Park JW, Lambert PF, Chung SH. Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice. Carcinogenesis. 2014;35(2):489–496. doi:10.1093/carcin/bgt350
   PubMed Web of Science ®Google Scholar
• Fan Q, Huang T, Sun X, et al. miR-130a-3p promotes cell proliferation and invasion by targeting estrogen receptor α and androgen receptor in cervical cancer. Exp Ther Med. 2021;21(5):414. doi:10.3892/etm.2021.9858
   PubMed Web of Science ®Google Scholar
• Baik S, Mehta FF, Chung SH. Medroxyprogesterone Acetate Prevention of Cervical Cancer through Progesterone Receptor in a Human Papillomavirus Transgenic Mouse Model. Am J Pathol. 2019;189(12):2459–2468. doi:10.1016/j.ajpath.2019.08.013
   PubMed Web of Science ®Google Scholar
• Wu Q, Shi D, Dou S, et al. Radiomics analysis of multiparametric MRI evaluates the pathological features of cervical squamous cell carcinoma. J Magn Reson Imaging. 2019;49(4):1141–1148. doi:10.1002/jmri.26301
   PubMed Web of Science ®Google Scholar
• Xiao M, Ma F, Li Y, et al. Multiparametric MRI-based radiomics nomogram for predicting lymph node metastasis in early-stage cervical cancer. J Magn Reson Imaging. 2020;52(3):885–896. doi:10.1002/jmri.27101
   PubMed Web of Science ®Google Scholar
• Yu YY, Zhang R, Dong RT, et al. Feasibility of an ADC-based radiomics model for predicting pelvic lymph node metastases in patients with stage IB-IIA cervical squamous cell carcinoma. Br J Radiol. 2019;92(1097):20180986. doi:10.1259/bjr.20180986
   PubMed Web of Science ®Google Scholar